Chicken Infectious Anemia: Symptoms, Causes and Vaccination

Chicken Anemia Virus (CAV) is a circovirus-like pathogen that specifically targets and destroys precursor cells in bone marrow and thymus, eliminating both red blood cell production and immune T-cell development simultaneously.

• Vertical transmission (primary): CAV-infected breeder hens without sufficient antibody titers transmit the virus through eggs. Chicks hatch already infected and develop clinical disease at 2-4 weeks when maternal antibody protection wanes. This is why breeder vaccination is the primary control tool.
• Horizontal fecal-oral transmission: CAV spreads efficiently in feces and respiratory secretions. Once in a flock, it spreads rapidly to all susceptible birds. The virus is extremely stable in the environment.
• Age-dependent susceptibility: Chicks under 2 weeks old are highly susceptible to fatal disease. Birds over 3-4 weeks old that are infected may develop subclinical immunosuppression without frank anemia. Adults are generally resistant but become lifelong carriers.
• Immunosuppressive amplification: CAV dramatically worsens outcomes for any concurrent infection. Flocks with CAV have higher mortality from Marek's, IBD, gangrenous dermatitis, and IBH than CAV-negative flocks facing the same pathogens.

CIA should be suspected in any flock with unexplained anemia, pallor, and increased susceptibility to secondary infections in 2-4 week old chicks.

• PCV (packed cell volume): Normal chicken PCV is 27-35%. CIA-affected chicks typically have PCV below 20%, and severe cases below 10%. This rapid field test confirms significant anemia.
• Bone marrow appearance: At necropsy, the bone marrow of CIA-affected birds is pale yellow (fat-replaced) rather than the normal pink-red. This is visible on cut section of the femur or tibiotarsus.
• Thymus atrophy: The thymus, visible in young chicks as paired lobes along the neck, is severely atrophied in CIA cases.
• Serology: ELISA or virus neutralization tests detect CAV antibodies in surviving birds or breeder flocks. PCR on blood or tissue confirms active infection.

There is no specific antiviral treatment for Chicken Infectious Anemia. Affected chicks require supportive care and secondary infection control.

Supportive care: Electrolytes and B vitamins (particularly B12, folate, and iron) support whatever residual hematopoietic function remains. High-quality nutrition and reduced stress limit additional losses.

Secondary infection control: Because CIA causes profound immunosuppression, secondary infections (bacterial, other viral) drive most of the mortality. Prophylactic broad-spectrum antibiotics during the acute phase reduce secondary bacterial septicemia.

Breeder vaccination (prevention, not treatment): Live CAV vaccine administered to breeders 4-6 weeks before peak egg production ensures maternal antibodies protect progeny. This is the only effective control measure.

• Vaccinate breeder flocks with a live CAV vaccine 4-6 weeks before hens enter the laying period. Adequate maternal antibody titers protect chicks through the critical 2-4 week susceptibility window.
• Test incoming breeder flocks for CAV antibody status. Seronegative breeders should be vaccinated before they begin laying to ensure progeny protection.
• Ensure IBD vaccination is current in breeder flocks. IBD and CIA co-infection dramatically worsens outcomes. Eliminating IBD protects against CIA-secondary disease expression.
• All-in, all-out flock management and thorough disinfection between flocks reduces environmental CAV burden. The virus is extremely environmentally stable but proper disinfection with sodium hydroxide or formalin is effective.